Boardwave
Impact Partner
Boardwave is an independent organisation, with an impact-driven business model, focussed on building a community of success amongst European software leaders. We have chosen Cure Parkinson's as our current Impact Partner. ​
Our funds are designed to support and build the Boardwave community through a range of programmes and events. We aim to donate any surplus funds beyond our operating needs to Cure Parkinson's.
​
Parkinson's Disease is a debilitating progressive neurological condition for which there is currently no cure. Today 10 million people around the world have Parkinson's Disease, estimates suggest this will double by 2033 – the world's fastest growing neurological condition.
As an example in the UK 1 in 37 people will be diagnosed in their lifetime.
​
Cure Parkinson's are here for the cure. Cure Parkinson’s is working with urgency to find new treatments to slow, stop and reverse Parkinson’s Disease.
​
Their funding and innovation has redefined the field of Parkinson’s Disease research, enabling the world’s leading researchers to prioritise the next generation of drugs for a clinical trial.
Cure Parkinson's have two of only six drugs in Phase III medical trials globally. Their impact and influence continue to exceed all expectations.
​
But their International Committee of leading neuroscientists have prioritised a further 43 drugs for urgent investigation, so we need a step change in funding to complete trials of these substances in the next five years.
​
The Cure Parkinson's Development Board are working tirelessly with the Cure Parkinson's team, and all its supporters to raise £40m to accelerate research. They do this in the knowledge that, due to their influence and track record, each pound raised will catalyse a ratio 7:1 of further funding from their network of partners.
They need your help!
Together we will conquer Parkinson’s Disease.
